North America Sterilization Equipment Market Outlook to 2033 - Chemical Sterilizers, Physical Sterilizers and Ultraviolet Sterilizers
Summary
GlobalData’s “North America Sterilization Equipment Market Outlook to 2033” is a comprehensive databook report, covering key market data on the North America Sterilization Equipment market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Chemical Sterilizers, Physical Sterilizers and Ultraviolet Sterilizers
The North America Sterilization Equipment Market report provides key information and data on -
Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
2023 company share and distribution share data for Sterilization Equipment Market.
Global corporate-level profiles of key companies operating within the North America Sterilization Equipment Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
Scope
North America Sterilization Equipment is segmented as follows -
Chemical Sterilizers
Physical Sterilizers
Ultraviolet Sterilizers
Reasons to Buy
North America Sterilization Equipment Market report helps you to develop -
Business strategies by identifying the key market segments poised for strong growth in the future.
Market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Sterilization Equipment Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Sterilization Equipment Market, North America
3.1 Sterilization Equipment Market, North America, Revenue ($m), 2018-2033
3.2 Sterilization Equipment Market, North America, Revenue ($m), 2018-2033
3.3 Sterilization Equipment Market, North America, Volume (Units), 2018-2033
3.4 Sterilization Equipment Market, North America, Volume (Units), 2018-2033
3.5 Sterilization Equipment Market, North America, Company Share by Revenue ($m), 2023
9.2.4 Apr 30, 2024: 3M First-Quarter Results Driven by Strong Operational Performance; Company Initiates Full-Year 2024 Guidance Reflecting Completion of Solventum Spin
9.2.5 Apr 19, 2024: Balchem Announces Quarterly Conference Call for First Quarter Financial Results on May 3, 2024
9.2.6 Feb 16, 2024: Balchem Reports Fourth Quarter and Full Year 2023 Financial Results
9.2.7 Feb 02, 2024: Balchem Announces Quarterly Conference Call for Fourth Quarter Financial Results on February 16, 2024
9.2.8 Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results
9.2.9 Jan 04, 2024: Hologic to Announce Financial Results for the First Quarter of Fiscal 2024 on Thursday, February 1, 2024
9.2.10 Nov 03, 2023: Cardinal Health Reports First Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook
9.2.11 Oct 27, 2023: Balchem Reports Third Quarter Sales of $229.9 Million, with Net Earnings of $29.1 Million, GAAP EPS of $0.90, and Adjusted EPS of $1.04
9.2.12 Oct 24, 2023: 3M Reports Third Quarter 2023 Results; Company Increases Full Year Adjusted Earnings and Cash Flow Expectations
9.3 Government and Public Interest
9.3.1 Sep 11, 2024: Medical Device Sterilization Town Hall: Sterility Master Files and Effective Use in Premarket Submissions
9.3.2 Jun 26, 2024: Balchem to Present at the CJS Securities 24th Annual New Ideas Summer Conference on July 10, 2024
9.3.3 May 21, 2024: FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics
9.3.4 Feb 07, 2024: Medical Device Sterilization Town Hall: Discussion of Premarket Submission Expectations and Additional Considerations for Sterility Review
9.4 Other Significant Developments
9.4.1 Oct 27, 2023: Balchem Reports Third Quarter Sales of $229.9 Million, with Net Earnings of $29.1 Million, GAAP EPS of $0.90, and Adjusted EPS of $1.04
9.5 Product News
9.5.1 Jul 17, 2024: Celerion Announces Launch of On-Site Services
9.5.2 Nov 09, 2023: New Testing Proves AURA Ion Bar Highly Effective in Combating COVID-19 and Other Airborne Pathogens